Literature DB >> 2122925

Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.

D M Baume1, M A Caligiuri, T J Manley, J F Daley, J Ritz.   

Abstract

The differential expression of the alpha and beta chains of the CD8 glycoprotein was examined in three functionally distinct cytolytic effector cell populations: (i) T cells (CD3+ CD56-), (ii) NK cells (CD56+ CD3-), and (iii) non-MHC-restricted T cells (CD56+ CD3+). Twenty-four percent of T cells were CD8+, and they consistently coexpressed both CD8 alpha and CD8 beta. Moreover, CD8+ T cells uniformly expressed high-density CD8 alpha. Forty percent of NK cells were CD8+ but the vast majority (approximately 75%) expressed only CD8 alpha without CD8 beta. In addition, CD8+ NK cells uniformly expressed low-density CD8 alpha. In comparison, 75% of non-MHC-restricted T lymphocytes were CD8+ but they displayed an intermediate phenotype: 60% coexpressed CD8 alpha and CD8 beta while 40% expressed only CD8 alpha. Within this population, CD8 alpha was expressed at high density, similar to that of T cells. Following IL-2 activation, enhancement of non-MHC-restricted cytotoxicity was not associated with any changes in either the quantitative or qualitative pattern of expression of CD8 alpha or CD8 beta by these cells. Addition of either anti-CD8 alpha or anti-CD8 beta mAb did not alter non-MHC-restricted cytotoxicity of either CD56+ CD3- or CD56+ CD3+ effector cells. However, within the CD56+ cell population, non-MHC-restricted cytotoxicity was almost entirely found within the CD8- and CD8 alpha + beta- populations, and both subsets displayed a similar level of killing. In contrast, CD8 alpha+ beta+ cells exhibited very little non-MHC-restricted cytotoxicity. Thus, the coexpression of CD8 alpha and CD8 beta in conjunction with the TCR/CD3 complex appears to characterize MHC restricted cells while the expression of CD8 alpha alone is associated with non-MHC-restricted cytotoxicity. Taken together, these findings suggest that neither CD8 alpha nor CD8 beta is involved in the initial phases of target cell binding or recognition during NK cell-mediated lysis. However, the selective expression of CD8 alpha by a large fraction of non-MHC-restricted effector cells suggests that this antigen may play a different functional role in this unique subset of cytolytic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122925     DOI: 10.1016/0008-8749(90)90260-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  18 in total

1.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

3.  T cell subsets in normal human epidermis.

Authors:  A L Spetz; J Strominger; V Groh-Spies
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

4.  Delineation of multiple subpopulations of natural killer cells in rhesus macaques.

Authors:  Ramothea L Webster; R Paul Johnson
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

Review 5.  Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy.

Authors:  Elie Mavoungou
Journal:  Clin Med Res       Date:  2006-03

6.  CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.

Authors:  Matthew S Sutton; Amy Ellis-Connell; Alexis J Balgeman; Gabrielle Barry; Andrea M Weiler; Scott J Hetzel; Yan Zhou; Annie W Lau-Kilby; Rosemarie D Mason; Kristin K Biris; John R Mascola; Nancy J Sullivan; Mario Roederer; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

7.  Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.

Authors:  M Suzuki; T Kikuchi; F Takatsuki; J Hamuro
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

8.  Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.

Authors:  M J Kuroda; J E Schmitz; W A Charini; C E Nickerson; C I Lord; M A Forman; N L Letvin
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 9.  Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.

Authors:  Michael R Verneris; Jeanette Baker; Matthias Edinger; Robert S Negrin
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

10.  Association of CD8 with p56lck is required for early T cell signalling events.

Authors:  N J Chalupny; J A Ledbetter; P Kavathas
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.